{
  "author": {
    "name": "Jonathan E Levitt Esq",
    "webUrl": "/author/profile/jonathan-e-levitt-esq/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 4,
    "social": [],
    "articles": [
      {
        "uri": "/2024/03/12/pharmacy-benefit-design-johnson-johnson-lawsuit-ushers-in-new-duty-of-prudence-standard/",
        "title": "Pharmacy benefit design: Johnson & Johnson lawsuit ushers in new 'duty of prudence' standard",
        "byline": "Jonathan E. Levitt, Esq. and Dae Y. Lee, Pharm.D., Esq., CPBS",
        "kicker": "Expert Opinion",
        "prettyDate": "March 12, 2024",
        "timeToRead": "9 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2024/03/Johnson-and-Johnson-PBM-Lawsuit-Animated-620x372-1.gif",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jonathan-e-levitt-esq/",
            "name": "Jonathan E. Levitt, Esq."
          },
          {
            "webUrl": "/author/profile/dae-y-lee-pharmd-esq-cpbs/",
            "name": "Dae Y. Lee, Pharm.D., Esq., CPBS"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "Regardless of its outcome, this class action will dramatically change pharmacy benefit management and the standard of care to which management will be held on benefit design.",
        "body": null
      },
      {
        "uri": "/2022/06/15/pbms-could-be-driving-up-plan-sponsors-drug-costs/",
        "title": "PBMs could be driving up plan sponsors' drug costs",
        "byline": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, and Adam C.  Farkas, Esq. ",
        "kicker": "",
        "prettyDate": "June 15, 2022",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/06/AdobeStock_2105272583.jpg",
          "width": "750",
          "height": "500"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jonathan-e-levitt-esq-dae-y-lee-pharmd-esq-cpbs/",
            "name": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS,"
          },
          {
            "webUrl": "/author/profile/adam-c-farkas-esq/",
            "name": "Adam C.  Farkas, Esq. "
          }
        ],
        "kickerNode": [],
        "summary": "Far too many pharmacy benefit managers (PBMs) thrive on opacity in their business operations, but sometimes public litigation shines the light of day on secretive practices.",
        "body": null
      },
      {
        "uri": "/2021/10/01/how-pbm-rebate-walls-impact-drug-spending-patient-care-and-competition/",
        "title": "How PBM \"rebate walls\" impact drug spending, patient care and competition",
        "byline": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, Jesse C. Dresser, Esq., Andreas Stargard, Esq.",
        "kicker": "Commentary",
        "prettyDate": "October 01, 2021",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/09/AdobeStock_53190533.jpg",
          "width": "750",
          "height": "498"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jonathan-e-levitt-esq-dae-y-lee-pharmd-esq-cpbs-jesse-c-dresser-esq-andreas-stargard-esq/",
            "name": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, Jesse C. Dresser, Esq., Andreas Stargard, Esq."
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Federal agencies and plan sponsors—the clients of PBMs—are beginning to explore perverse PBM incentives and are waking up to abusive PBM practices.",
        "body": null
      },
      {
        "uri": "/2020/05/20/plan-sponsor-alert-truths-about-pbm-and-manufacturer-rebates/",
        "title": "Plan sponsor alert: truths about PBM and manufacturer rebates",
        "byline": "Jonathan E. Levitt, Esq. and Dae Y. Lee, Pharm.D., Esq., CPBS",
        "kicker": "Expert Opinion",
        "prettyDate": "May 20, 2020",
        "timeToRead": "7 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/05/shutterstock_173587901-1.jpg",
          "width": "750",
          "height": "615"
        },
        "authors": [
          {
            "webUrl": "/author/profile/jonathan-e-levitt-esq/",
            "name": "Jonathan E. Levitt, Esq."
          },
          {
            "webUrl": "/author/profile/dae-y-lee-pharmd-esq-cpbs/",
            "name": "Dae Y. Lee, Pharm.D., Esq., CPBS"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "Plan sponsors should consult with industry experts who have an in-depth knowledge of the PBM industry and who understand PBMs' lingo to uncover self-serving rebate arrangement.",
        "body": null
      }
    ]
  }
}